Table 1.
Correlations between circREPS2 expression and clinicopathological parameters in GC patients
| Characteristics | Total |
CircREPS2 expression |
P value | |
|---|---|---|---|---|
| (N=60) | Low (%) n=44 | High (%) n=16 | ||
| Gender | ||||
| Male | 39 | 28 (71.8) | 11 (28.2) | 0.482 |
| Female | 21 | 16 (76.2) | 5 (23.8) | |
| Age (year) | ||||
| <60 | 19 | 14 (73.7) | 5 (26.3) | 0.613 |
| ≥60 | 41 | 30 (73.2) | 11 (26.8) | |
| Differentiation grade | ||||
| Good | 31 | 19 (61.3) | 12 (39.7) | 0.0414∗ |
| Poor | 29 | 25 (86.2) | 4 (13.8) | |
| Tumor size | ||||
| <5 cm | 30 | 17 (56.7) | 13 (43.3) | 0.007∗∗ |
| ≥5 cm | 30 | 27 (90) | 3 (10) | |
| Lymph node | ||||
| N0 | 26 | 19 (73.1) | 7 (26.9) | 0.598 |
| N1-N2 | 34 | 25 (73.5) | 9 (26.5) | |
| TNM stage | ||||
| 1+2 | 25 | 13 (52) | 12 (48) | 0.002∗∗ |
| 3+4 | 35 | 31 (88.6) | 4 (11.4) | |
| Distant metastasis | ||||
| M0 | 51 | 37 (77.5) | 14 (22.5) | 0.99 |
| M1 | 9 | 7 (77.8) | 2 (22.2) | |
The TNM staging system is based on the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M) ∗P<0.05, ∗∗P<0.01.